Skip to main content
SpringerLink
Log in

Experience with the Peponen® capsule in the management of benign prostatic hyperplasia

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Sixty patients in Stages I and II of benign prostatic hyperplasia were treated with Peponen® capsule. Out of them 26 took the drug for 10 months, 22 for at least 7, and 12 for at least 4 months. The daily dosage was 3×2 capsules in the first month and 3×1 capsule for the rest of the time. On the ground of urodynamic test results and changes in subjective complaints, more than 80% of the patients experienced improvement. The therapy intensified the uroflow, appeased dysuria, the difficult and painful discharge, and reduced the frequency of nocturnal urination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Altwein, J. E., Jacobi, G. H.: Urologie, Enke Verlag, Stuttgart 1986.

    Google Scholar 

  2. Balogh, F. (ed.): Urológia. Medicina, Budapest 1986.

    Google Scholar 

  3. Balogh, F.: The effect of Raveron in the treatment of certain urologic diseases (in Hungarian).Urol. Nephrol. Szle, 14, 195 (1987).

    Google Scholar 

  4. Bartsch, G.: Light microscopic stereological analysis of normal human prostate and of benign prostatic hyperplasia.J. Urol., 122, 487 (1979).

    PubMed  CAS  Google Scholar 

  5. Eggerhart, G., Gallyas, F.: Klinische Erfahrungen mit Harzöl-Kapseln in der Behanlung des Prostata-Adenoms.Urologe [B],27, 227 (1987).

    Google Scholar 

  6. Frang, D., Hamvas, A., Nagy, F.: Experience with the alfa-adrenoceptor blocking Prazosin (Minipress) in the management of bladder neck adenoma (submitted).

  7. May, P., Sökeland, P.: Phytotherapie in der Urologie. Editorial.Urologe [B],27, 313 (1987).

    Google Scholar 

  8. Pintér, J. (ed.): Prostatic hyperplasia. Vth Congress of the Hungarian Urologic Society, Debrecen 1979.

  9. Romics, I.: Observations with Bazoton® in the management of prostatic hyperplasia.Int. Urol. Nephrol., 19, 293 (1987).

    PubMed  CAS  Google Scholar 

  10. Ruszinkó, B.: Experience obtained by the use of Peponen capsules. Test report. Biogal. 1986.

  11. Sonnenschein, R.: Untersuchung der Wirksamkeit eines prostatotropen Phytotherapeutikums (Urtica plus) bei benigner Hyperplasie und Prostatitis—eine multizentrische Studie.Urologe [B],27, 232 (1987).

    Google Scholar 

  12. Khoury, S. (ed.): Ultrasound in urology.Found. Int. Sci., 309 (1985).

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Semmelweis University Medical School, Budapest, Hungary

    A. Hamvas, Gy. Corradi, M. Hegedüs & D. Frang

Authors
  1. A. Hamvas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gy. Corradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Hegedüs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Frang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamvas, A., Corradi, G., Hegedüs, M. et al. Experience with the Peponen® capsule in the management of benign prostatic hyperplasia. International Urology and Nephrology 23, 51–55 (1991). https://doi.org/10.1007/BF02549728

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549728

Keywords

Search

Navigation